SCHEMBL6371033

SCHEMBL6371033

CCOc1cc(OC)c(N=C=O)cc1C

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HPGD P15428 1/20 0.49
▸ PDE4A P27815 3/20 0.39
▸ PDE4B Q07343 3/20 0.39
▸ PDE4C Q08493 3/20 0.39
▸ PDE4D Q08499 3/20 0.39
▸ TRPA1 O75762 1/20 0.37
▸ TSHR P16473 2/20 0.36
▸ HTT P42858 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ AMY1A P0DUB6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6372027 0.87 CYP3A4 (0.58) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL6371313 0.82 ALDH1A1 (0.44) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL9623392 0.81 CYP3A4 (0.42) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL9825110 0.80 CYP3A4 (0.58) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL542562 0.79 CYP3A4 (0.43) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL8163649 0.79 CYP3A4 (0.66) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL1774055 0.78 CYP3A4 (0.51) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL6372278 0.77 CYP3A4 (0.63) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL542663 0.77 CYP3A4 (0.68) CYP3A4TDP1ALDH1A1HPGDTRPA1
SCHEMBL13696472 0.76 ALDH1A1 (0.53) CYP3A4TDP1ALDH1A1HPGDTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250816-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2005-11-10 — — US disclosed
US-20040254373-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2004-12-16 — — US disclosed
US-20040249150-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2004-12-09 — — US disclosed
US-20030236287-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PHARMACIA & UPJOHN COMPANY 2003-12-25 — — US disclosed
WO-2003093250-A2 POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR PHARMACIA & UPJOHN COMPANY (US) 2003-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254373-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 CYP3A4 1352/4885TDP1 1321/4885ALDH1A1 2007/4885
US-20030236287-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 CYP3A4 1352/4885TDP1 1321/4885ALDH1A1 2007/4885
US-20040249150-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 CYP3A4 1352/4885TDP1 1321/4885ALDH1A1 2007/4885
US-20050250816-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA7, CHRNA1, CHRNA5 CYP3A4 1339/4885TDP1 2203/4885ALDH1A1 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback